pe
pep-05269 v1 CC-BY-SA-4.0

β-defensin 124 anticancer peptide

A lab-made peptide being studied for its potential to fight cancer cells; experimental, not an approved drug.

statusbioassayed targetANTICANCER length52 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.612
avg pLDDT63.9
ranking score0.633
STRUCTURE · PEP-05269 × ANTICANCER
ranking0.633
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence52 aa
1510152025303540455052
LALGHMQPGRSEF KRCWKGQGACRTY CTRQETYLHMCPD ASLCCLPYGSRPL
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6333442330360413 boltz-2
3-letter notation
Leu-Ala-Leu-Gly-His-Met-Gln-Pro-Gly-Arg-Ser-Glu-Phe-Lys-Arg-Cys-Trp-Lys-Gly-Gln-Gly-Ala-Cys-Arg-Thr-Tyr-Cys-Thr-Arg-Gln-Glu-Thr-Tyr-Leu-His-Met-Cys-Pro-Asp-Ala-Ser-Leu-Cys-Cys-Leu-Pro-Tyr-Gly-Ser-Arg-Pro-Leu
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). β-defensin 124 anticancer peptide (pep-05269, v1). PeptideModel. https://peptidemodel.com/card/pep-05269
@peptide{pep05269,
  sequence = {LALGHMQPGRSEFKRCWKGQGACRTYCTRQETYLHMCPDASLCCLPYGSRPL},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use